Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms.
Holkova B, Perkins EB, Ramakrishnan V, Tombes MB, Shrader E, Talreja N, Wellons MD, Hogan KT, Roodman GD, Coppola D, Kang L, Dawson J, Stuart RK, Peer C, Figg WD Sr, Kolla S, Doyle A, Wright J, Sullivan DM, Roberts JD, Grant S. Holkova B, et al. Among authors: perkins eb. Clin Cancer Res. 2011 May 15;17(10):3388-97. doi: 10.1158/1078-0432.CCR-10-2876. Epub 2011 Mar 29. Clin Cancer Res. 2011. PMID: 21447728 Free PMC article. Clinical Trial.
A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2.
Holkova B, Supko JG, Ames MM, Reid JM, Shapiro GI, Perkins EB, Ramakrishnan V, Tombes MB, Honeycutt C, McGovern RM, Kmieciak M, Shrader E, Wellons MD, Sankala H, Doyle A, Wright J, Roberts JD, Grant S. Holkova B, et al. Among authors: perkins eb. Clin Cancer Res. 2013 Apr 1;19(7):1873-83. doi: 10.1158/1078-0432.CCR-12-2926. Epub 2013 Mar 20. Clin Cancer Res. 2013. PMID: 23515411 Free PMC article. Clinical Trial.
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies.
Bose P, Perkins EB, Honeycut C, Wellons MD, Stefan T, Jacobberger JW, Kontopodis E, Beumer JH, Egorin MJ, Imamura CK, Douglas Figg W Sr, Karp JE, Koc ON, Cooper BW, Luger SM, Colevas AD, Roberts JD, Grant S. Bose P, et al. Among authors: perkins eb. Cancer Chemother Pharmacol. 2012 Jun;69(6):1657-67. doi: 10.1007/s00280-012-1839-5. Epub 2012 Feb 15. Cancer Chemother Pharmacol. 2012. PMID: 22349810 Free PMC article. Clinical Trial.
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma.
Yazbeck V, Shafer D, Perkins EB, Coppola D, Sokol L, Richards KL, Shea T, Ruan J, Parekh S, Strair R, Flowers C, Morgan D, Kmieciak M, Bose P, Kimball A, Badros AZ, Baz R, Lin HY, Zhao X, Reich RR, Tombes MB, Shrader E, Sankala H, Roberts JD, Sullivan D, Grant S, Holkova B. Yazbeck V, et al. Among authors: perkins eb. Clin Lymphoma Myeloma Leuk. 2018 Sep;18(9):569-575.e1. doi: 10.1016/j.clml.2018.05.023. Epub 2018 Jun 6. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30122201 Clinical Trial.
Phase I trial of bortezomib (PS-341; NSC 681239) and "nonhybrid" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms.
Holkova B, Kmieciak M, Perkins EB, Bose P, Baz RC, Roodman GD, Stuart RK, Ramakrishnan V, Wan W, Peer CJ, Dawson J, Kang L, Honeycutt C, Tombes MB, Shrader E, Weir-Wiggins C, Wellons M, Sankala H, Hogan KT, Colevas AD, Doyle LA, Figg WD, Coppola D, Roberts JD, Sullivan D, Grant S. Holkova B, et al. Among authors: perkins eb. Clin Cancer Res. 2014 Nov 15;20(22):5652-62. doi: 10.1158/1078-0432.CCR-14-0805. Epub 2014 Sep 23. Clin Cancer Res. 2014. PMID: 25248382 Free PMC article. Clinical Trial.
Genetic mapping of Uba3 O.2.2 , a pupal lethal mutation in Drosophila melanogaster.
Mast E, Bieser KL, Abraham-Villa M, Adams V, Akinlehin AJ, Aquino LZ, Austin JL, Austin AK, Beckham CN, Bengson EJ, Bieszk A, Bogard BL, Brennan RC, Brnot RM, Cirone NJ, Clark MR, Cooper BN, Cruz D, Daprizio KA, DeBoe J, Dencker MM, Donnelly LL, Driscoll L, DuBeau RJ, Durso SW, Ejub A, Elgosbi W, Estrada M, Evins K, Fox PD, France JM, Franco Hernandez MG, Garcia LA, Garl O, Gorsuch MR, Gorzeman-Mohr MA, Grothouse ME, Gubbels ME, Hakemiamjad R, Harvey CV, Hoeppner MA, Ivanov JL, Johnson VM, Johnson JL, Johnson A, Johnston K, Keller KR, Kennedy BT, Killian LR, Klumb M, Koehn OL, Koym AS, Kress KJ, Landis RE, Lewis KN, Lim E, Lopez IK, Lowe D, Luengo Carretero P, Lunaburg G, Mallinder SL, Marshall NA, Mathew J, Mathew J, Mcmanaway HS, Meegan EN, Meyst JD, Miller MJ, Minogue CK, Mohr AA, Moran CI, Moran A, Morris MD, Morrison MD, Moses EA, Mullins CJ, Neri CI, Nichols JM, Nickels BR, Okai AM, Okonmah C, Paramo M, Paramo M, Parker SL, Parmar NK, Paschal J, Patel P, Patel D, Perkins EB, Perry MM, Perry Z, Pollock AA, Portalatin O, Proffitt KS, Queen JT, Quemeneur AC, Richardson AG, Rosenberger K, Rutherford AM, Santos-Perez IX, Sarti CY, Schouweiler LJ, Sessing LM, Setaro SO, Sil… See abstract for full author list ➔ Mast E, et al. Among authors: perkins eb. MicroPubl Biol. 2022 Mar 18;2022:10.17912/micropub.biology.000542. doi: 10.17912/micropub.biology.000542. eCollection 2022. MicroPubl Biol. 2022. PMID: 35622528 Free PMC article.
12 results